Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate

Patent metadata

Field	Value
Publication number	US-11518771-B2
Application number	US-202117326382-A
Country	US
Kind code	B2
Filing date	May 21, 2021
Priority date	May 22, 2020
Publication date	Dec 6, 2022
Grant date	Dec 6, 2022

Abstract

This invention relates to a novel process for making alkyl 7-amino-5-methyl-[1,2,5]-oxadiazolo[3,4-b]pyridine-carboxylate.

First claim

The invention claimed is:

1. A process for making alkyl 7-amino-5-methyl-[1,2,5]-oxadiazolo[3,4-b]pyridine-carboxylate 4

wherein R is C 1-3 -alkyl,
comprising
(a) reacting malononitrile with sodium nitrite in the presence of a suitable acid under slight overpressure;
(b) reacting the reaction mixture obtained by step (a) with a suitable toluenesulfonic acid derivative to obtain compound 1;

(c) optionally isolating compound 1;
(d) reacting compound 1 in a suitable solvent with hydroxylamine to obtain compound 2;

(e) optionally isolating compound 2;
(f) cyclisation of compound 2 in the presence of a base under heating to about 70° C. in a suitable solvent to obtain the oxadiazole 3;

(g) removal of the by-product water formed in step (f) from the reaction mixture by evaporation under reduced pressure;
(h) removal of p-toluensulfonic acid salt(s) by filtration;
(i) in situ-condensation of compound 3 in the reaction mixture obtained after step (h) with the appropriate beta-keto ester of formula

wherein R is C 1-3 -alkyl, in the presence of a Lewis acid in a suitable solvent; and

(j) isolating compound 4.

2. The process according to claim 1 characterized in that isolation step (c) is carried out prior to reaction compound 1 is step (d).

3. The process according to claim 1 characterized in that step (e) is carried out prior to the cyclisation of compound 2 in step (f).

4. The process according to claim 1 characterized in that in step (a), hydrochloric acid, hydrobromic acid or acetic acid is used as the suitable acid and using water as the suitable solvent.

5. The process according to claim 1 characterized in that step (a) is carried out under an overpressure of up to 0.3 bar at a temperature of 0-25° C.

6. The process according to claim 1 characterized in that in step (a), hydrobromic acid is used as the suitable acid; using water as the suitable solvent; and at a temperature of 0-20° C.

7. The process according to claim 1 characterized in that in step (b) the suitable toluenesulfonic acid derivative is toluenesulfonic acid anhydride or toluenesulfonic acid chloride, and the reaction is carried out at a temperature of 10 to 30° C.

8. The process according to claim 1 characterized in that in step (b) the suitable toluenesulfonic acid derivative is toluenesulfonic acid chloride, and the reaction is carried out at a temperature of about 20° C.

9. The process according to claim 1 characterized in that in step (c), compound 1 is precipitated via addition of an antisolvent and then isolated via filtration.

10. The process according to claim 1 characterized in that in step (c), compound 1 is precipitated via addition of an alcohol and then isolated via filtration.

11. The process according to claim 1 characterized in that in step (c), compound 1 is precipitated via addition of 2-propanol and then isolated via filtration.

12. The process according to claim 1 characterized in that in step (d), the reaction is carried out at a temperature of 10 to 30° C. and in a solvent comprising ethers, alcohols, water, or mixtures thereof.

13. The process according to claim 1 characterized in that in step (d), the reaction is carried out at a temperature of 20 to 25° C. and in a solvent comprising tetrahydrofuran, 2-propanol, water, or mixtures.

14. The process according to claim 1 characterized in that in step (e), compound 2 is precipitated via addition of an antisolvent and then isolated via filtration.

15. The process according to claim 1 characterized in that in step (e), compound 2 is precipitated via addition of water and then isolated via filtration.

16. The process according to claim 1 characterized in that in step (f), the cyclisation is carried out in the presence of triethylamine, an alkali carbonate or an alkali hydrogencarbonate; in a solvent comprising ethers, water, or mixtures thereof; and at a temperature of 20 to 100° C.

17. The process according to claim 1 characterized in that in step (f), the alkali carbonate is selected from the group consisting of lithium carbonate, sodium carbonate and potassium carbonate; the alkali hydrogencarbonate is selected from the group consisting of lithium hydrogencarbonate, sodium hydrogencarbonate and potassium hydrogencarbonate; the ether is 1,4-dioxane; and the temperature is 60 to 80° C.

18. The process according to claim 1 characterized in that in step (i), the in situ-condensation is carried out in the presence of a zinc salt as Lewis acid at a temperature of 20 to 100° C., in a solvent selected from an ether, an alcohol, water, or mixtures thereof.

19. The process according to claim 1 characterized in that in step (i), the in situ-condensation is carried out in the presence of zinc dichloride as Lewis acid; at a temperature of 60 to 80° C.; and using 1,4-dioxane as a solvent.

20. The process according to claim 1 characterized in that in step (j), compound 4 is precipitated via addition of an antisolvent and then isolated via filtration.

21. The process according to claim 1 characterized in that in step (j), compound 4 is precipitated via addition of water and then isolated via filtration.

22. The process according to claim 1 wherein R is ethyl.

Assignees

• Boehringer Ingelheim Int

Inventors

• Linz Guenter
• Daeubler Juergen
• Pangerl Michael
• Schmid Rolf
• Unger Sarah

Classifications

• C07D498/04 Primary

  Ortho-condensed systems · CPC title